Skip to main content

Month: December 2020

Post Holdings Issues 2020 Environmental, Social and Governance Report

ST. LOUIS, Dec. 07, 2020 (GLOBE NEWSWIRE) — Post Holdings, Inc. (NYSE:POST), a consumer packaged goods holding company, today released its 2020 Environmental, Social and Governance (ESG) report. The report details sustainability achievements, including accomplishments in the areas of water stewardship, effectively managing waste, sustainable packaging, responsible sourcing and community involvement. A special section on the company’s response to COVID-19, detailing additional employee safety measures and charitable support in the communities where Post operates, is also detailed.“I am quite pleased to share Post’s inaugural report highlighting our commitment to ESG,” said Rob Vitale, President and Chief Executive Officer. “This report begins to highlight the large and small ways that Post companies contribute to the overall purpose...

Continue reading

Form 8.3 – Octopus Investments – IMImobile plc

FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1.         KEY INFORMATION2.         POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should...

Continue reading

Automotive Plastics Market to Reach USD 53.85 Billion by 2027; Backed by Increasing Adoption of Additive Manufacturing Technology Globally, Says Fortune Business Insights™

Pune, India, Dec. 07, 2020 (GLOBE NEWSWIRE) — The global automotive plastics market size is expected to hit USD 53.85 billion by 2027. This is attributable to the rising automotive sector and the growing demand for additive manufacturing in the automotive sector during the forecast period. This information is published by Fortune Business Insights, in its latest report, titled, “Automotive Plastics Market Size, Share & COVID-19 Impact Analysis, By Type (Polypropylene, Polyurethane, Polyamide, Polyvinylchloride, Acrylonitrile Butadiene Styrene, Polycarbonate, Polyethylene, and Others), By Application (Interior, Exterior, and Under Bonnet), and Regional Forecast, 2020-2027.” The report further observes that the market stood at USD 40.91 billion in 2019 and is likely to exhibit a CAGR of 5.3% between 2020 and 2027.COVID-19 Leads...

Continue reading

Intrado Digital Media Launches Do-it-Yourself Offering: Virtual Event Express

OMAHA, Neb., Dec. 07, 2020 (GLOBE NEWSWIRE) — Intrado Corporation (“Intrado” or the “Company”), a global leader in technology-enabled services, today announced the addition of Virtual Event Express to their Digital Media solutions portfolio. Virtual Event Express is a self-service platform that streamlines the creation of online events. Customers with access to Intrado’s Studio Webcasting platform can now build a complete virtual event environment in hours, rather than weeks or months.“The increased demand for virtual events calls for innovation in the space,” said Ben Chodor, President of Intrado Digital Media. “With Virtual Event Express, we make virtual events available and accessible to a wider audience by significantly lowering the barriers to entry – cost, setup time, and support. As a result, our customers will be able to...

Continue reading

Apellis Reports Pegcetacoplan Demonstrates Greater Treatment Responses and Quality-of-Life Improvements Compared to C5 Inhibitors for PNH

Data were presented at the American Society of Hematology (ASH) Annual MeetingIn an analysis from the 16-week Phase 3 PEGASUS study, 70.7% of patients treated with pegcetacoplan compared to 5.1% of eculizumab-treated patients achieved a good, major, or complete hematologic response based on published classificationsQuality–of–life substantially improved for pegcetacoplan-treated patients, reaching near-normal levels on several measures, and did not change for eculizumab-treated patients in a PEGASUS analysis at 16 weeksA matching–adjusted indirect comparison suggests that 76% more patients on pegcetacoplan achieved hemoglobin stabilization and 71% more patients on pegcetacoplan were transfusion free compared to ravulizumab, a long-acting C5 inhibitorWALTHAM, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc....

Continue reading

ALX Oncology Announces Updated Data from ASPEN-01, the Ongoing Phase 1b Study of ALX148, Showing Robust, Durable Activity in Patients with Non-Hodgkin Lymphoma

— ORR of 70.0% Observed in Patients with NHL Treated with Higher Doses of ALX148 with Median Duration of Response Not Yet Reached— Significant Improvement in Clinical Response Demonstrated with Increased ALX148 ExposureBURLINGAME, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO), a clinical-stage immuno-oncology company developing therapies to block the CD47 checkpoint pathway, today announced the presentation of updated clinical data from its ongoing trial evaluating ALX148 in combination with rituximab for the treatment of patients with advanced relapsed and refractory (“r/r”) non-Hodgkin lymphoma (“NHL”). The new results, shared in a poster at the 62nd American Society of Hematology (“ASH”) Annual Meeting, show that the combination of ALX148 and rituximab is highly...

Continue reading

Kymera Therapeutics Presents Preclinical Data on IRAKIMiD and STAT3 Programs at Virtual 62nd American Society of Hematology (ASH) Annual Meeting

WATERTOWN, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company advancing targeted protein degradation to deliver novel, small molecule protein degrader therapeutics, today announced the company presented preclinical data that further support development of its highly selective and potent IRAKIMiD and STAT3 protein degraders scheduled to enter the clinic in 2021. Data were presented at the virtual 62nd American Society of Hematology (ASH) Annual Meeting, Dec. 5-8, 2020 in three separate poster presentations.IRAKIMiD ProgramABSTRACT #2088, “KTX-120, A Novel IRAKIMiD Degrader of IRAK4 and IMiD Substrates, Shows Preferential Activity and Induces Regressions in MYD88-Mutant DLBCL Cell and Patient Derived Xenograft Models,” presented by Duncan H. Walker, PhD, Vice President of...

Continue reading

Sage and GCPay Strengthen Partnership to Help Streamline the Subcontractor Payment Process

ATLANTA and PORTLAND, Ore., Dec. 07, 2020 (GLOBE NEWSWIRE) — Sage (FTSE: SGE), the market leader in cloud business management solutions, and GCPay, the leading web-based platform for managing the subcontractor pay application process, today announced a strengthened partnership. Sage will now offer GCPay as an add-on with its industry-leading construction solutions, Sage 300 Construction and Real Estate and Sage 100 Contractor.“Managing subcontractor invoicing and payment processes is a source of frustration for many construction firms,” said Dustin Anderson, vice president of Sage Construction and Real Estate. “It usually entails back and forth emails or calls to address issues such as incorrect billings, unapproved change orders, missing lien waivers, or expired compliance documents. Our partnership with GCPay helps to eliminate...

Continue reading

ISG to Release Study on Providers of Mainframe Transformation and Modernization Services

STAMFORD, Conn., Dec. 07, 2020 (GLOBE NEWSWIRE) — Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm, has launched a research study examining service providers that support the modernization, transformation and use of mainframe computers in enterprise settings.The study results will be published in a comprehensive ISG Provider Lens™ report, called Mainframe Services & Solutions, scheduled to be released in April. The report will cover vendors that offer mainframe transformation and application modernization services as well as mainframe-as-a-service and storage-as-a-service offerings.Enterprise buyers will be able to use information from the report to evaluate their current vendor relationships, potential new engagements and available offerings, while ISG advisors use the information...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.